47 results
8-K
EX-99
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
AEON Biopharma Reports First Quarter 2024 Financial Results
4:07pm
ended March 31, 2023, and a Successor period for the three months ended March 31, 2024. A black line between the Successor and Predecessor periods has
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
, which can be administered orally or by nasal spray. Approved metoclopramide medications include a black box warning that the use of the medication … includes the periods through July 21, 2023 concurrent with the Merger, and the successor period from July 22, 2023 through December 31, 2023. A black
8-K
EX-99.1
kljphbjkbhcdhi 6edp
29 Mar 24
AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
3:46pm
8-K
EX-99.1
mluv lpgnodh
13 Nov 23
AEON Biopharma Reports Third Quarter 2023 Financial Results
9:00am
8-K
EX-99.2
y8yzlh2a
19 Oct 23
AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine
4:23pm
8-K/A
EX-99.8
sbv8fu5e41f6fycb1c
11 Aug 23
Financial Statements and Exhibits
9:12pm